Article thumbnail

Assessment of the Risk/Benefit Ratio of Phase II Cancer Clinical Trials by Institutional Review Board (IRB) members

By A.W. Musschenga, R.B. Keus, W.M. Robinson and N.K. Aaronson
Year: 2003
DOI identifier: 10.1093/annonc/mdf209
OAI identifier: oai:dare.ubvu.vu.nl:1871/44197
Provided by: DSpace at VU
Journal:
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://hdl.handle.net/1871/441... (external link)
  • Suggested articles


    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.